Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, presenting promising enhancements across numerous healthcare and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA delivers a safer, more reputable alternative for therapeutic use, s